Safety and efficacy of caplacizumab retreatment in a real-life monocentric cohort of patients with immune-mediated thrombotic thrombocytopenic purpura

Caocci, G.
Co-prime
;
Mulas, O.
Co-prime
;
Bandinu, N.;La Nasa, G.
Last
2023-01-01

2023
Caplacizumab; TTP retreatment; Thrombotic thrombocytopenic purpura
Files in This Item:
File Size Format  
pagination_TR_8776.pdf

open access

Type: versione post-print
Size 419.4 kB
Format Adobe PDF
419.4 kB Adobe PDF View/Open

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.

Questionnaire and social

Share on:
Impostazioni cookie